Search - tctmd.com

Displaying 41 - 60 of 62

Sort: Relevancy | Date

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow

Presenter: Rasha Al-Lamee

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

Presenter: Rasha Al-Lamee

May 05, 2018

Podcast TCTMD Talking Points

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

May 02, 2018

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

L.A. McKeown

April 26, 2018

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2012

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

Presenter: Rasha Al-Lamee

October 23, 2012

Video

» Interview

ACC 2025 Day 1 Wrap-Up

March 29, 2025

Video

» Conference Wrap-Up

TCT 2024 Day 3 Wrap-Up

October 29, 2024

Video

» Interview

Beyond the Data: ORBITA-COSMIC

April 15, 2024

Partner Content

Optimizing Clinical Decision Making with the CathWorks FFRangio® System

March 19, 2024

Video

» Interview

Beyond the Data: ORBITA-2

November 11, 2023

Video

» Conference Wrap-Up

TCT 2023 Day 3 Wrap-Up

October 25, 2023

Advertisement

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

ACC 2025 Day 1 Wrap-Up

TCT 2024 Day 3 Wrap-Up

Beyond the Data: ORBITA-COSMIC

Optimizing Clinical Decision Making with the CathWorks FFRangio® System

Beyond the Data: ORBITA-2

TCT 2023 Day 3 Wrap-Up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content